key: cord-0427832-reg2jz1a authors: Ayerbe, L.; Risco-Risco, C.; Martinez-Urbistondo, D.; Caro-Tinoco, M. E.; Ayis, S. title: Trends in Covid-19 hospital mortality in women and men date: 2021-09-13 journal: nan DOI: 10.1101/2021.09.06.21263166 sha: ddfe8500e81bf1f264d6dfe4d069947b819debd4 doc_id: 427832 cord_uid: reg2jz1a Introduction: It remains unclear if the development of health services, clinical management, and scientific evidence, during the pandemic is associated with better medical outcomes, sustained in the long term, for Covid-19 patients of each gender. This study presents the trends in mortality associated with Covid-19 for women and men during the first year of the pandemic. Methods: This study was based in 17 Spanish hospitals. Sociodemographic, clinical, and mortality data from all patients with Covid-19, who had been discharged alive, or had died after being admitted, between March 2020 and February 2021, were used. The association between time of admission and mortality was examined with multivariate logistic regression models. Results: 3390 Covid-19 patients were included in the study, of which 1330 were women, the age was M(SD): 66.55(16.55) Death was reported for 451 patients. There was a significant decreasing trend in mortality by time of admission for the whole year with an OR: 0.86(0.77-0.96) p=0.005. No significant trend in mortality for women was observed OR: 1.00(0.85-1.19) p=0.959, while there was a significant decreasing trend for men OR: 0.78 (0.68-0.90) p=0.001 Discussion: The health policies put in place, the scientific evidence developed by researchers, and the experienced acquired by clinicians, are likely to explain this improvement in mortality. More epidemiological and clinical studies addressing trends of mortality in patients with different sociodemographic and clinical profile and the improvement of clinical outcomes are required. Future research may address the safety and efficacy of interventions specifically in female patients. mortality data from all patients with Covid-19, who had been discharged alive, or had died after being admitted, between March 2020 and February 2021, were used. The association between time of admission and mortality was examined with multivariate logistic regression models. Results: 3390 Covid-19 patients were included in the study, of which 1330 were women, the age was M(SD): 66.55(16.55) Death was reported for 451 patients. There was a significant . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint At the beginning of the pandemic caused by SARS-CoV-2 clinicians experienced a sudden increase in their workload. There was an insufficient number of beds available in hospital wards and intensive care units. The scientific evidence on the management of the infection was also very limited at the time. This all made difficult to provide an adequate healthcare. This study was based in the 17 Spanish hospitals of the private healthcare provider HM Hospitales, placed in the provinces of Barcelona, Coruña, León, Madrid, Pontevedra, and Toledo. 7 Sociodemographic, clinical, and mortality data from all patients with Covid-19, who had been discharged alive, or had died after being admitted, between March 2020 and February 2021, were used. Patients who were still admitted at the end of the study period, or had been transferred to another hospital, were not included. All patients had been diagnosed with polymerase chain reaction test of respiratory samples for SARS-CoV-2. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted September 13, 2021. ; https://doi.org/10.1101/2021.09.06.21263166 doi: medRxiv preprint Time of admission was categorized in three-months period, March to May 2020, June to August 2020, September to November 2020, and December 2020 to February 2021. The association between time of admission and mortality was examined with logistic regression models, first univariate, then adjusted for age and gender, and finally also adjusted for saturation of oxygen on admission. 8 This association was then examined separately for women and men. Sensitivity analysis was conducted with time of admission categorized in four-month periods, which made the number of individuals and events larger in each time category. The software Stata 11 was used for all the analysis. A total of 3390 Covid-19 patients were included in the study, of which 1330 were women, . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this this version posted September 13, 2021. ; https://doi.org/10.1101/2021.09.06.21263166 doi: medRxiv preprint There was a significant decreasing trend in mortality among patients admitted with in the first year of the pandemic, with the largest reduction in deaths in the first few months. This decrease was significant for male, but not for female, patients. The health policies put in place, the scientific evidence developed by researchers, and the experienced acquired by clinicians, are likely to explain this improvement in mortality. Treatments that mainly address the immune response to the infection, which is implicated in the higher mortality for men, may explain why the death rate in women does not improve. 1, 9, 10 Behavioural changes among women, around the prevention of Covid-19, care for relatives, or seeking medical help, during the pandemic, may have increased their risk. 9 It is also possible that the lower number of female patients included in the study and the reduced statistical power for the analysis, compared to the one available for male patients, may have not allowed to observe a decreasing trend in mortality. This study has strengths and limitations. Patients were not randomized and the differences in mortality may be explained by factors other than the development of health services, clinical management, and scientific evidence. However, it should be noted that a randomized study investigating all these factors in different months would not be feasible. The observation of a large number of patients, all those discharged from 17 hospitals, the adjustment of statistical models for reported predictors of mortality, 8 is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Update to living systematic review on drug treatments for covid-19 Trends in COVID-19 Risk-Adjusted Mortality Rates Trends in Risk-Adjusted 28-Day Mortality Rates for Patients Hospitalized with COVID-19 in England Trends in Patient Characteristics and COVID-19 In-Hospital Mortality in the United States During the COVID-19 Trends in 30-day mortality from COVID-19 among older adults in the Veterans Affairs system Trends in mortality of hospitalised COVID-19 patients: A single centre observational cohort study from Spain. Lancet Reg Health Eur Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain The Physiological Mechanisms of the Sex-Based Difference in Outcomes of COVID19 Infection Front Physiol Thank you to all clinicians and administrators of Hospitales HM (Spain) on which data this study is based. Ethical Approval: The Ethics Committe to HM Hospitales approved this study References . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprintThe copyright holder for this this version posted September 13, 2021. ; https://doi.org/10.1101/2021.09.06.21263166 doi: medRxiv preprint It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Nature Reviews Immunology volume 20, pages442-447 (2020). CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprintThe copyright holder for this this version posted September 13, 2021. ; https://doi.org/10.1101/2021.09.06.21263166 doi: medRxiv preprint